🇺🇸 FDA
Pipeline program

6-month clopidogrel therapy

EXCELLENT

Approved small_molecule completed

Quick answer

6-month clopidogrel therapy for Coronary Artery Disease is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Coronary Artery Disease
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials